MedTrace Logo

Bimatoprost for the Treatment of Eyebrow Hypotrichosis

NCT01765764 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 357

Last updated 2019-04-23

Study results available
· View outcomes & findings →

Summary

This study will evaluate the safety and efficacy of bimatoprost solution compared with vehicle in the treatment of eyebrow hypotrichosis (inadequate eyebrows).

Conditions

  • Eyebrow Hypotrichosis

Interventions

DRUG

bimatoprost solution

Bimatoprost solution once a day or twice a day applied to each eyebrow for 7 months.

DRUG

Vehicle to bimatoprost solution

Vehicle to bimatoprost solution once or twice a day applied to each eyebrow for 7 months.

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-13
Primary Completion
2014-01-31
Completion
2014-02-11

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01765764 on ClinicalTrials.gov